To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06016738
Title OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)
Acronym OPERA-01
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Olema Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | POL | NLD | ITA | HUN | GBR | FRA | ESP | DEU | CZE | CAN | BRA | BGR | BEL | AUS | ARG

Facility Status City State Zip Country Details
Clinical Trial Site Tucson Arizona 85724 United States Details
Clinical Trial Site Fountain Valley California 92708 United States Details
Clinical Trial Site La Jolla California 92093 United States Details
Clinical Trial Site Los Angeles California 90027 United States Details
Clinical Trial Site Whittier California 90602 United States Details
Clinical Trial Site Aurora Colorado 80045 United States Details
Clinical Trial Site Denver Colorado 80218 United States Details
Clinical Trial Site Golden Colorado 80401 United States Details
Clinical Trial Site Grand Junction Colorado 81505 United States Details
Clinical Trial Site Danbury Connecticut 06810 United States Details
Clinical Trial Site Newark Delaware 19713 United States Details
Clinical Trials Site Jacksonville Florida 32223 United States Details
Clinical Trial Site Margate Florida 33063 United States Details
Clinical Trial Site Orlando Florida 32804 United States Details
Clinical Trial Site Plantation Florida 33324 United States Details
Clinical Trial Site Tamarac Florida 33321 United States Details
Clinical Trial Site Atlanta Georgia 30322 United States Details
Clinical Trial Site Chicago Illinois 60616-2315 United States Details
Clinical Trial Site Chicago Illinois 60637 United States Details
Clinical Trial Site Urbana Illinois 61801 United States Details
Clinical Trial Site Baton Rouge Louisiana 70809 United States Details
Clinical Trial Site Baltimore Maryland 21201 United States Details
Clinical Trial Site Boston Massachusetts 02111 United States Details
Clinical Trial Site Saint Louis Park Minnesota 55426 United States Details
Clinical Trial Site Lincoln Nebraska 68510-2496 United States Details
Clinical Trial Site Farmington New Mexico 87401 United States Details
Clinical Trial Site New York New York 10032 United States Details
Clinical Trial Site Port Jefferson Station New York 11776 United States Details
Clinical Trial Site Dayton Ohio 45409 United States Details
Clinical Trial Site Toledo Ohio 43623 United States Details
Clinical Trial Site Portland Oregon 97239 United States Details
Clinical Trial Site Nashville Tennessee 37203 United States Details
Clinical Trial Site Nashville Tennessee 37208 United States Details
Clinical Trial Site Dallas Texas 75246 United States Details
Clinical Trial Site Dallas Texas 75390 United States Details
Clinical Trial Site Houston Texas 77030 United States Details
Clinical Trial Site Spokane Washington 99204 United States Details
Clinical Trial Site Spokane Washington 99218 United States Details
Clinical Trial Site San Salvador De Jujuy Jujuy 4600 Argentina Details
Clinical Trial Site Viedma Río Negro R8500ACE Argentina Details
Clinical Trial Site Rosario Santa Fe S2013DTC Argentina Details
Clinical Trial Site Rosario Santa Fe S2013KDS Argentina Details
Clinical Trial Site San Miguel De Tucumán Tucumán 4000 Argentina Details
Clinical Trial Site Buenos Aires C14626ABP Argentina Details
Clinical Trial Site Córdoba X5000HHW Argentina Details
Clinical Trial Site Córdoba X5008HHW Argentina Details
Clinical Trial Site La Rioja 5300 Argentina Details
Clinical Trial Site Gosford New South Wales 2250 Australia Details
Clinical Trial Site Westmead New South Wales 2145 Australia Details
Clinical Trial Site Adelaide South Australia 5000 Australia Details
Clinical Trial Site Ballarat Central Victoria 3355 Australia Details
Clinical Trial Site Clayton Victoria 3168 Australia Details
Clinical Trial Site Shepparton Victoria 3630 Australia Details
Clinical Trial Site Nedlands Western Australia 6009 Australia Details
Clinical Trial Site Edegem Antwerpen 2650 Belgium Details
Clinical Trial Site Woluwe-Saint-Lambert Brussels 1200 Belgium Details
Clinical Trial Site Charleroi Hainaut 6000 Belgium Details
Clinical Trial Site Leuven Vlaams Brabant Belgium Details
Clinical Trial Site Salvador Bahia 40050-410 Brazil Details
Clinical Trial Site Belo Horizonte Minas Gerais 30150-221 Brazil Details
Clinical Trial Site Recife Pernambuco 50070-480 Brazil Details
Clinical Trial Site Porto Alegre Rio Grande Do Sul 90035-903 Brazil Details
Clinical Trial Site Porto Alegre Rio Grande Do Sul 90050-170 Brazil Details
Clinical Trial Site Itajaí Santa Catarina 88301-220 Brazil Details
Clinical Trial Site Sorocaba São Paulo 18060-105 Brazil Details
Clinical Trial Site Rio De Janeiro 20560-120 Brazil Details
Clinical Trial Site Panagyurishte Pazardzhik 4500 Bulgaria Details
Clinical Trial Site Sofia Sofia-Grad 1407 Bulgaria Details
Clinical Trial Site Vratsa 3000 Bulgaria Details
Clinical Trial Site Calgary Alberta T2N 4N2 Canada Details
Clinical Trial Site Montréal Quebec H4A 3J1 Canada Details
Clinical Trial Site Hradec Králové Královéhradecký Kraj 500 12 Czechia Details
Clinical Trial Site Nový Jičín Moravskoslezský Kraj 741 01 Czechia Details
Clinical Trial Site Olomouc Olomoucký Kraj 799 00 Czechia Details
Clinical Trial Site Bourg-en-Bresse Ain 01012 France Details
Clinical Trial Site Besançon Doubs 25030 France Details
Clinical Trial Site Nantes Loire-Atlantique 44805 France Details
Clinical Trial Site Compiègne Oise 60200 France Details
Clinical Trial Site Clermont-Ferrand Puy-de-Dôme 63011 France Details
Clinical Trial Site Le Mans Sarthe 72015 France Details
Clinical Trial Site Villejuif Val-de-Marne 94085 France Details
Clinical Trial Site Montpellier 34070 France Details
Clinical Trial Site Karlsruhe Baden-Württemberg 76135 Germany Details
Clinical Trial Site Krefeld Nordrhein-Westfalen 47805 Germany Details
Clinical Trial Site Velbert Nordrhein-Westfalen 42551 Germany Details
Clinical Trial Site Dresden Sachsen 01307 Germany Details
Clinical Trial Site Central 100176 Hong Kong Details
Clinical Trial Site Central 999077 Hong Kong Details
Clinical Trial Site Hong Kong 999077 Hong Kong Details
Clinical Trials Site Hong Kong 999077 Hong Kong Details
Clinical Trial Site Kowloon 999077 Hong Kong Details
Clinical Trial Site Pécs Baranya 7624 Hungary Details
Clinical Trial Site Kecskemét Bács-Kiskun 6000 Hungary Details
Clinical Trial Site Debrecen Hajdú-Bihar 4032 Hungary Details
Clinical Trial Site Avellino Campania 83100 Italy Details
Clinical Trial Site Bologna Emilia-Romagna 40138 Italy Details
Clinical Trial Site Meldola Emilia-Romagna 47014 Italy Details
Clinical Trial Site Modena Emilia-Romagna 41124 Italy Details
Clinical Trial Site Reggio Emilia Emilia-Romagna 42100 Italy Details
Clinical Trial Site Udine Friuli-Venezia Giulia 33100 Italy Details
Clinical Trial Site Roma Lazio 00144 Italy Details
Clinical Trial Site Roma Lazio 00168 Italy Details
Clinical Trial Site Milano Lombardia 20141 Italy Details
Clinical Trial Site Rozzano Lombardia 20089 Italy Details
Clinical Trial Site Alessandria Piemonte 15121 Italy Details
Clinical Trial Site Pavia 27100 Italy Details
Clinical Trial Site Suwon-si Gyeonggi-do 16247 Korea, Republic of Details
Clinical Trial Site Busan 49201 Korea, Republic of Details
Clinical Trial Site Seoul 2841 Korea, Republic of Details
Clinical Trial Site Seoul 3080 Korea, Republic of Details
Clinical Trial Site Seoul 3722 Korea, Republic of Details
Clinical Trial Site Seoul 5505 Korea, Republic of Details
Clinical Trial Site Seoul 6273 Korea, Republic of Details
Clinical Trial Site Seoul 6591 Korea, Republic of Details
Clinical Trial Site Seoul 8308 Korea, Republic of Details
Clinical Trial Site Suwon 16499 Korea, Republic of Details
Clinical Trials Site Sungai Petani Kedah 8000 Malaysia Details
Clinical Trial Site Kota Bharu Kelantan 16150 Malaysia Details
Clinical Trial Site George Town Penang 10450 Malaysia Details
Clinical Trial Site Ipoh Perak 30450 Malaysia Details
Clinical Trial Site Putrajaya Putramya 62250 Malaysia Details
Clinical Trial Site Kuching Sarawak 93586 Malaysia Details
Clinical Trial Site Petaling Jaya Selangor 46050 Malaysia Details
Clinical Trial Site Kuala Lumpur WP 59100 Malaysia Details
Clinical Trial Site Zapopan Jalisco 45070 Mexico Details
Clinical Trial Site Monterrey 64116 Mexico Details
Clinical Trial Site Oaxaca 68020 Mexico Details
Clinical Trial Site Sinaloa 80230 Mexico Details
Clinical Trial Site Rotterdam Zuid-Holland 3083 AN Netherlands Details
Clinical Trial Site Łódź Lódzkie 90-349 Poland Details
Clinical Trial Site Otwock Mazowieckie 05-400 Poland Details
Clinical Trial Site Brzozów Podkarpackie 36-200 Poland Details
Clinical Trial Site Rzeszów Podkarpackie 35-922 Poland Details
Clinical Trial Site Gdynia Pomorskie 81-519 Poland Details
Clinical Trial Site Skórzewo Wielkopolskie 60-185 Poland Details
Clinical Trial Site Wrocław 50-450 Poland Details
Clinical Trial Site Matosinhos Porto 4454-509 Portugal Details
Clinical Trial Site Coimbra 3000-075 Portugal Details
Clinical Trial Site Lisboa 1099-023 Portugal Details
Clinical Trial Site Lisboa 1500-473 Portugal Details
Clinical Trial Site Porto 4050-428 Portugal Details
Clinical Trial Site Mayaguez 00682-6391 Puerto Rico Details
Clinical Trial Site Oradea Bihor 410469 Romania Details
Clinical Trial Site București Bucuresti 014141 Romania Details
Clinical Trial Site Cluj-Napoca Cluj 400015 Romania Details
Clinical Trial Site Craiova Dolj 200385 Romania Details
Clinical Trial Site Timisoara Timis 300239 Romania Details
Clinical Trial Site Brașov 500152 Romania Details
Clinical Trial Site Iași 700106 Romania Details
Clinical Trial Site Pamplona Navarra 31008 Spain Details
Clinical Trial Site Alicante 03015 Spain Details
Clinical Trial Site Badajoz 06080 Spain Details
Clinical Trial Site León 24071 Spain Details
Clinical Trial Site Lleida 25198 Spain Details
Clinical Trial Site Madrid 28033 Spain Details
Clinical Trial Site Madrid 28050 Spain Details
Clinical Trial Site Santiago De Compostela 15706 Spain Details
Clinical Trial Site Valencia 46010 Spain Details
Clinical Trial Site Changhua 500 Taiwan Details
Clinical Trial Site Kaohsiung 80756 Taiwan Details
Clinical Trial Site Taichung 40447 Taiwan Details
Clinical Trial Site Taichung 433 Taiwan Details
Clinical Trial Site Tainan City 736 Taiwan Details
Clinical Trial Site Taipei city 111 Taiwan Details
Clinical Trial Site Taipei city 114 Taiwan Details
Clinical Trial Site Taipei 100 Taiwan Details
Clinical Trial Site Taipei 11217 Taiwan Details
Clinical Trial Site Bangkok 10300 Thailand Details
Clinical Trial Site Bangkok 10330 Thailand Details
Clinical Trial Site Bangkok 10700 Thailand Details
Clinical Trial Site Chiang Mai 50180 Thailand Details
Clinical Trial Site Samut Sakhon 74120 Thailand Details
Clinical Trial Site Songkhla 90110 Thailand Details
Clinical Trial Site London EC1M 6BQ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field